Team

Pushing the boundaries in everything we do.

We’re driven by the idea that medicines of the future will be generated, not discovered.

Founded in 2018 by Flagship Pioneering, Generate Biomedicines is the latest in a long line of unprecedented multi-product platform companies like Moderna Therapeutics, Rubius Therapeutics, Indigo Agriculture, and Sana Biotechnology. These companies have pioneered breakthroughs in a variety of life sciences fields. Our leadership team has a track record of successfully pursuing new ideas and are committed to the extraordinary mission of generative medicines.

Leadership

  • Avak Kahvejian

    Founding Co-CEO & Director
    Generate Biomedicines
    General Partner
    Flagship Pioneering

  • Geoffrey von Maltzahn

    Founding Co-CEO & Director
    Generate Biomedicines
    General Partner
    Flagship Pioneering

  • Lovisa Afzelius

    President
    Generate Biomedicines
    Partner
    Flagship Pioneering

  • Molly Gibson

    Co-Founder and Chief Innovation Officer
    Generate Biomedicines
    Principal
    Flagship Pioneering

  • Gevorg Grigoryan

    Co-Founder and Chief Technology Officer
    Generate Biomedicines

  • Raffi Afeyan

    Vice President, Product Strategy and Innovation
    Generate Biomedicines

  • Andy Beam

    Head of Machine Learning
    Generate Biomedicines

  • Jake Feala

    Head of Computational Biology
    Generate Biomedicines

  • Kristen Hopson

    Head of Immunology and Oncology
    Generate Biomedicines

  • Stephen Kottmann

    Head of Informatics
    Generate Biomedicines

  • Adam Root

    Head of Protein Sciences
    Generate Biomedicines

  • James Villa

    Head of Platform Strategy and Operations
    Generate Biomedicines

Board of Directors

  • Noubar Afeyan

    Chair of the Board
    Generate Biomedicines
    Co-Founder and CEO
    Flagship Pioneering

  • Frances Arnold

    Director
    Generate Biomedicines
    Nobel Laureate, Professor
    California Institute for Technology

  • Stéphane Bancel

    Director
    Generate Biomedicines
    CEO
    Moderna

  • Avak Kahvejian

    Founding Co-CEO & Director
    Generate Biomedicines
    General Partner
    Flagship Pioneering

  • Gary Pisano

    Director
    Generate Biomedicines
    Harry Figgie Professor of Business Administration
    Harvard Business School

  • Geoffrey von Maltzahn

    Founding Co-CEO & Director
    Generate Biomedicines
    General Partner
    Flagship Pioneering

Our people work across disciplines to advance ideas and science together.

Generative Biology is only possible through a true integration of scientific disciplines. We are a close-knit group of cross-disciplinary experts in machine learning, biological engineering, and medicines, each conversant in one another’s fields, working together to create a new one.

  • Machine Learning

    Rather than discovering new medicines, we are using powerful machine learning techniques to generate them directly from the hidden principles we uncover. Generation allows us to overcome the combinatorial problem of discovery and significantly expand the number of potential medicines.

    • Alex Ramos—Principal Scientist, Computational Biology
    • Andy Beam—Head of Machine Learning
    • Brinda Monian—Scientist, Computational Biology
    • Craig Mackenzie—Scientist, Structural Biology
    • Gevorg Grigoryan—Co-Founder and Chief Technology Officer
    • Jake Feala—Head of Computational Biology
    • Jenhan Tao—Scientist, Computational Biology
    • John Ingraham—Senior Scientist, Machine Learning
    • Luis Lebolo—Senior Software Engineer
    • Max Baranov—Engineer, Machine Learning
    • Meghan Franklin—Scientist, Structural Biology
    • Saketh Saxena—Engineer, Computational Biology
    • Stephen Kottmann—Head of Informatics
    • Vince Frappier—Scientist, Machine Learning
    • Vincent Xue—Scientist, Machine Learning
    • Zak Costello—Scientist, Machine Learning
  • Biological Engineering

    Our data pipelines and automation infrastructure allow production of high-quality data that is powered to learn generalizable rules of biology at scale.

    Every protein we generate is assayed for a compendium of functions, allowing us to continually enhance our understanding of underlying principles of proteins as well as the principals of each medicine we generate.

    • Adam Root—Head of Protein Sciences
    • Alan Leung—Senior Scientist, Protein Engineering
    • Aldo Costa—Lab Manager
    • Ben Manning—Scientist, Protein Sciences
    • Doug Gobron—Senior Research Associate, Next-Generation Sequencing
    • Frank Poelwijk—Senior Scientist, Platform Innovation
    • Kinjal Mehta—Associate Director, Protein Sciences
    • Kirsten Brand—Research Associate, Protein Sciences
    • Patricia Timpug—Research Associate, Protein Sciences
    • Reshica Baral—Senior Research Associate, Protein Sciences
    • Robin Green—Scientist, Protein Sciences
    • Ross Federman—Scientist, Protein Engineering
    • Ziyu Song—Research Associate, Medicines
  • Medicines

    The proteins we generate are rapidly advanced to disease models, allowing us to bring the generation of medicines as close to patients in need as possible.

    • Ali Bootwala—Research Associate, Immunology
    • Dan Leventhal—Senior Scientist, Immunology
    • Kristen Hopson—Head of Immunology and Oncology
  • Strategy & Innovation
    • Joe Cabral—Associate, Flagship Pioneering
    • Molly Gibson—Co-Founder and Chief Innovation Officer
    • Raffi Afeyan—Vice President, Product Strategy and Innovation
Join

View open positions.